CoChat

Mesenchymal stromal cells: what have we learned so far about their therapeutic potential and mechanisms of action?

Open access
Amadeo, Francesco, Trivino Cepeda, Katherine, Littlewood, James, Wilm, Bettina, Taylor, Arthur, Murray, Patricia · 2021 · Emerging Topics in Life Sciences

The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.

Abstract

Mesenchymal stromal cells (MSCs) have been found to be safe and effective in a wide range of animal models of human disease. MSCs have been tested in thousands of clinical trials, but results show that while these cells appear to be safe, they tend to lack efficacy. This has raised questions about whether animal models are useful for predicting efficacy in patients. However, a problem with animal studies is that there is a lack of standardisation in the models and MSC therapy regimes used; there appears to be publication bias towards studies reporting positive outcomes; and the reproducibility of results from animal experiments tends not to be confirmed prior to clinical translation. A further problem is that while some progress has been made towards investigating the mechanisms of action (MoA) of MSCs, we still fail to understand how they work. To make progress, it is important to ensure that prior to clinical translation, the beneficial effects of MSCs in animal studies are real and can be repeated by independent research groups. We also need to understand the MoA of MSCs to assess whether their effects are likely to be beneficial across different species. In this review, we give an overview of the current clinical picture of MSC therapies and discuss what we have learned from animal studies. We also give a comprehensive update of what we know about the MoA of MSCs, particularly in relation to their role in immunomodulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/etls20210013

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Distribution MSC trials registered as complete on clinicaltrials.gov, classified by specialty. A total of 327 studies were found using the terms ‘mesenchymal stem cells’ OR ‘mesenchymal stromal cells’.
Figure 1. Distribution MSC trials registered as complete on clinicaltrials.gov, classified by specialty. A total of 327 studies were found using the terms ‘mesenchymal stem cells’ OR ‘mesenchymal stromal cells’.CC BY · PubMed Central
Figure 2. Potential mechanisms by which MSCs might act.
Figure 2. Potential mechanisms by which MSCs might act.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 125 references

Cited by

Metadata

Authors
Amadeo, F., Trivino Cepeda, K., Littlewood, J., Wilm, B., Taylor, A., & Murray, P.
Affiliations
  • University of Liverpool (GB)
  • Department of Molecular Physiology and Cell Signalling, Integrative Biology, University of Liverpool, Crown Street, L69 3GE Liverpool, U.K.
Corresponding author
Murray, Patricia
Venue
Emerging Topics in Life Sciences
Published
2021-09-08
Volume
5
Issue
4
Pages
549-562
ISSN
  • 2397-8554 (ISSN-L)
  • 2397-8562
OpenAlex
W3196765138
Cited by
20
References
125
Citations by year
2026: 3 · 2025: 5 · 2023: 7 · 2022: 4 · 2021: 1
FWCI
0.43
Type
journal article
Language
en
Open access
Locations
  • Emerging Topics in Life Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
European Commission (HORIZON2020, 813839)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords
mesenchymal stem cells, cell therapy, mechanism of action, immunomodulation, animal models, clinical translation, reproducibility, publication bias, treatment efficacy, translational research
MeSH terms
Animals, Humans, Immunity, Reproducibility of Results, Mesenchymal Stem Cell Transplantation, Immunomodulation, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.